1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Waldenstrom Macroglobulinemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Denizot, Y; Dupuis, F; Praloran, V; Trimoreau, F; Verger, C | 1 |
| Denizot, Y; Dupuis, F; Liozon, E; Praloran, V; Trimoreau, F | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Waldenstrom Macroglobulinemia
| Article | Year |
|---|---|
Platelet-activating factor concentrations in bone marrow of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Aged; Bone Marrow; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |
Decreased levels of platelet-activating factor in blood of patients with lymphoid and nonlymphoid hematologic malignancies.
Topics: Adolescent; Adult; Aged; Female; Humans; Leukemia; Lymphoma; Male; Middle Aged; Platelet Activating Factor; Waldenstrom Macroglobulinemia | 1995 |